Athanor Capital’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Athanor Capital’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-3,430	Closed	-$148K	–	1082
2020 Q4	$148K	Buy	+3,430	New	+$154K	﹤0.01%	678
2020 Q3	–	Sell	-4,315	Closed	-$259K	–	695
2020 Q2	$259K	Buy	+4,315	New	+$395K	0.01%	443
2020 Q1	–	Sell	-2,280	Closed	-$314K	–	379
2019 Q4	$314K	Sell	2,280 -50	-2%	-$6.08K	0.01%	304
2019 Q3	$277K	Buy	2,330 +900	+63%	+$126K	0.02%	195
2019 Q2	$200K	Buy	+1,430	New	+$251K	0.03%	131

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Athanor Capital's ORTX Position: Q1 2021 in Review

Athanor Capital sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2021, closing a stake of 3,430 shares — an estimated $148K sold.

Athanor Capital first reported a position in ORTX in Q2 2019 and held it in 5 quarters. The position peaked at $314K in Q4 2019. 83 funds tracked by Wall St. Rank hold ORTX as of Q1 2021.

Athanor Capital reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Athanor Capital sold 3,430 Orchard Therapeutics plc American Depositary Shares shares in Q1 2021, an estimated $148K.
Athanor Capital first reported a position in Orchard Therapeutics plc American Depositary Shares in Q2 2019 and held it in 5 quarters.
Athanor Capital's Orchard Therapeutics plc American Depositary Shares position peaked at $314K in Q4 2019.
83 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2021.

Based on Athanor Capital's 13F filing for Q1 2021, filed 14 May 2021.